Cytolytics develops small molecule drugs, medical devices, and safety devices for medical doctors. We harvest intellectual property from Universities and develop the product further to generate our own intellectual property and take it to market.
Many of our projects are still in early stages. We do have a patented safety device for doctors exposed to x-rays during surgery. Current devices available are proven to be ineffective and doctors are just starting to realize it. Doctors that do these types of procedures can develop cataracts and brain tumors. Our device virtually eliminates all x-ray exposure to doctors and staff doing these types of surgeries which has been proven with testing.
The CEO of Cytolytics, Dr. Don Anderson, is a seasoned PhD in Biochemistry and also holds an MBA. He received his PhD from Cornell University and has been in academics and the biotech industry for over 20 years. He was recently an integral part of Peloton Therapeutics which developed a new drug and was purchased by Merck and Co for $2.2 billion. He has been a consultant for Merck and Scientist making key discoveries that have been further developed.
Ready to Ask For Funding for your company?
Post a Funding Request